Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?_老虎社区_美港股上老虎

Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?

Zacks2021-06-17

Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

pseudomeow
·2021-06-17
Up up up!!!
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2144717905?lang=zh_CN&edition=full","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1dxLXSY5A2hCscEl8bQjIA--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/p7mMbEOF_0HXQZ7ayoNiSw--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b37fb2516d615eeca7b35dab54b82078","is_english":true,"pubTime":"2021-06-17 13:15","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2144717905","market":"us","top_or_hot":-1,"title":"Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?","media":"Zacks","content":"<div>\n<p>Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...</p>\n\n<a href=\"https://finance.yahoo.com/news/altimmune-inc-alt-soars-16-051505879.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAltimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 13:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/altimmune-inc-alt-soars-16-051505879.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...</p>\n\n<a href=\"https://finance.yahoo.com/news/altimmune-inc-alt-soars-16-051505879.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRCT","symbol_name":"Cricut, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/altimmune-inc-alt-soars-16-051505879.html","article_id":"2144717905","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1dxLXSY5A2hCscEl8bQjIA--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/p7mMbEOF_0HXQZ7ayoNiSw--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b37fb2516d615eeca7b35dab54b82078"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2144717905","pubTimestamp":1623906905,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. The move was","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRCT":"Cricut, Inc.","ALT":"Altimmune, Inc.","TERN":"Terns Pharmaceuticals, Inc."},"translate_title":"Altimmune公司(ALT)暴涨16.5%：该股还会有更大的上涨空间吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALT":1,"CRCT":1,"TERN":1},"content_text":"Altimmune, Inc. ALT shares soared 16.5% in the last trading session to close at $16.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.4% gain over the past four weeks.\nEncouraging interim data from an early-stage weight loss study on its GLP-1/glucagon dual receptor agonist candidate, ALT-801, drove share prices on Wednesday. The company has several other pipeline candidates, including COVID-19 vaccine and therapeutic candidates. Positive clinical data will drive shares prices further high.\nThis company is expected to post quarterly loss of $0.26 per share in its upcoming report, which represents a year-over-year change of +72.3%. Revenues are expected to be $3.84 million, up 432.9% from the year-ago quarter.\nWhile earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.\nFor Altimmune, Inc., the consensus EPS estimate for the quarter has been revised 25.7% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ALT going forward to see if this recent jump can turn into more strength down the road.\nThe stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nAltimmune, Inc. (ALT) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":161219517,"gmtCreate":1623928179339,"gmtModify":1634025776329,"author":{"id":"3574924039602922","authorId":"3574924039602922","name":"pseudomeow","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3574924039602922","authorIdStr":"3574924039602922"},"htmlText":"Up up up!!!","listText":"Up up up!!!","text":"Up up up!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161219517","repostId":2144717905,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}